Higher activity of the inducible nitric oxide synthase contributes to very early onset inflammatory bowel disease. - Wikidata - awgldk - TriplyDB

Higher activity of the inducible nitric oxide synthase contributes to very early onset inflammatory bowel disease.

Higher activity of the inducible nitric oxide synthase contributes to very early onset inflammatory bowel disease.

http://www.wikidata.org/entity/Q41910113

about

Angiogenesis in Inflammatory Bowel Disease Genetic disorders coupled to ROS deficiency Inducible Nitric Oxide Synthase Polymorphisms and Nitric Oxide Levels in Individuals with Chronic Periodontitis.Role of polymorphisms of inducible nitric oxide synthase and endothelial nitric oxide synthase in idiopathic environmental intolerances.Defects in NADPH Oxidase Genes NOX1 and DUOX2 in Very Early Onset Inflammatory Bowel Disease Immune Complex-Induced, Nitric Oxide-Mediated Vascular Endothelial Cell Death by Phagocytes Is Prevented with Decoy FcγReceptors Functional Inducible Nitric Oxide Synthase Gene Variants Associate With Hypertension: A Case-Control Study in a Finnish Population-The TAMRISK Study ROS in gastrointestinal inflammation: Rescue Or Sabotage?Keratin 8-deletion induced colitis predisposes to murine colorectal cancer enforced by the inflammasome and IL-22 pathway.Luteolin suppresses the JAK/STAT pathway in a cellular model of intestinal inflammation.Inducible Nitric Oxide Synthase in the Carcinogenesis of Gastrointestinal Cancers.Diethylcarbamazine: possible therapeutic alternative in the treatment of alcoholic liver disease in C57BL/6 mice.Variants in TRIM22 That Affect NOD2 Signaling Are Associated With Very-Early-Onset Inflammatory Bowel Disease.High-resolution gene expression profiling using RNA sequencing in patients with inflammatory bowel disease and in mouse models of colitis.Protein Kinase R Mediates the Inflammatory Response Induced by Hyperosmotic Stress.6-Mercaptopurine reduces macrophage activation and gut epithelium proliferation through inhibition of GTPase Rac1.The C-Type Lectin Mincle: Clues for a Role in Crohn's Disease Adjuvant Reaction.Nitric Oxide: The Forgotten Child of Tumor Metabolism.Suppression of chronic inflammation with engineered nanomaterials delivering nuclear factor κB transcription factor decoy oligodeoxynucleotides.An integrated network analysis identifies how ArcAB enables metabolic oscillations in the nitric oxide detoxification network of Escherichia coli.Effect of riboflavin-producing bacteria against chemically induced colitis in mice.Inducible Nitric Oxide Regulates Brush Border Membrane Na-Glucose Co-transport, but Not Na:H Exchange via p38 MAP Kinase in Intestinal Epithelial Cells

P2860

Q26769945-5349B4A8-ED21-4175-B0EF-367A5F3F327B Q26799545-D40FC173-8248-44C6-AC7D-3137C0228367 Q33838436-51F4AB4E-9093-4DC8-8E9B-40D92427B39F Q35296216-9F4113EC-8FB8-4320-969C-5DF36140AD05 Q35964479-435860AE-1CE1-4169-96EA-87A818913A20 Q35996121-7059265E-EA66-41D5-8C7A-930EADCC8444 Q36299263-1CB00977-1001-4296-B600-AB2B05F328ED Q38693962-8878FD2D-486C-4FC1-9797-323FF682BFE1 Q38768002-94AB18EF-58FA-4733-AB9B-B8DE04D63B6A Q38773024-5B492E7B-C452-4F9D-AF14-D58F17E0BB4C Q38802590-CFA2E9D6-9927-4CA6-BA36-0FEB4B1A7125 Q39039913-063C6926-3E37-49BD-B4FD-CF519EA2A279 Q40533140-C7ACFF6F-4D02-42DB-9B94-AB1A5DF797BD Q41185159-06B5CACC-583B-4EA0-9C12-1C1DA4709CA3 Q42324571-65322157-5E62-4A93-BFB8-E35844D8AEFC Q44698407-FCD53501-34CD-4D35-9CA7-EC5DCB117BDC Q46318718-9095D2DD-A4F5-47CF-9A7B-AE415CA8D980 Q47722572-A865E784-818A-4D0D-8F31-2EFD69F70568 Q47859509-DA9A13E1-3A83-4711-8C7E-16738B443C52 Q47909181-B04FF73A-0C8E-45D7-81B7-D63FA7ACEFED Q48109659-60E28BB8-E6CC-4D0B-8214-B09B05583406 Q58766261-3D94F25C-A0A0-42EB-B4E9-E8D4D66C9DCE

P2860

Higher activity of the inducible nitric oxide synthase contributes to very early onset inflammatory bowel disease.

http://www.wikidata.org/entity/Q41910113

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Higher activity of the inducib ...... et inflammatory bowel disease.

@en

type

label

Higher activity of the inducib ...... et inflammatory bowel disease.

@en

prefLabel

Higher activity of the inducib ...... et inflammatory bowel disease.

@en

P1433

Q41910113-7DA3D1CF-F97B-4653-99D3-FA3A389893A0

P1476

Q41910113-17B7392F-4529-4B39-B2FA-75A46CFB42A9

P2093

Q41910113-0F9E5222-A842-4CA8-8421-B9C6F1EF8169

Q41910113-2B0A311F-EF3C-4822-8FF1-1FC7FAC4BB9D

Q41910113-363A264F-9E12-480F-966C-0F4476C3BD27

Q41910113-3ADB8DD7-6F3E-4D51-B4B3-70E616242D59

Q41910113-42E6BF21-4BBE-469D-8D0F-AEEACDDC0884

Q41910113-43E828A9-D6CC-4DEB-8EC8-5AD7558A0143

Q41910113-48AF03FA-18DC-4332-8B1C-2FEFC6B9C4A9

Q41910113-578B679E-4871-4D88-9B2F-F614E4DC739B

Q41910113-5F690CF0-4799-4BA5-B85C-0ACD64B925DC

Q41910113-67AE97E8-8620-4691-BC36-13F67205775F

P2860

Q41910113-0F9A4F4C-41BA-4EDC-83CE-100481A96F9D

Q41910113-1D622B5E-4F83-4525-87D8-8F72AFBC4929

Q41910113-1E50E519-6209-45E0-9501-78A55C8FCF95

Q41910113-1F04BF54-7478-4EA9-A5F9-A10C11992B11

Q41910113-24B1ECC0-B597-4078-A454-40FCEFD9B694

Q41910113-2A0D436F-5489-4D9F-93E2-0EC7224BBC5D

Q41910113-45994777-2538-4318-9084-6BA1869449BC

Q41910113-468DB16A-DBF9-46F7-A499-2D8DCE153E77

Q41910113-50151AB7-2433-4750-B407-0FFF772E0727

Q41910113-51C04F2B-5AF0-46CA-A4CE-3BAED0AFE762

P304

Q41910113-16F33A4B-AA0B-4BB3-BC5C-CC2440692B8A

P31

Q41910113-CAE93F52-52F7-41FA-854A-1529FF986495

P356

Q41910113-B7BFBE97-7376-4881-9A52-4B9A9BF741C6

P478

Q41910113-12EE9656-D29F-4D7B-8FAB-82E119D7A87F

P577

Q41910113-E968F8E0-EE5E-4EDC-B592-AE4B49157500

P5875

Q41910113-E49AB103-896A-4610-BC93-1EE01C4E57A0

P698

Q41910113-80ECF064-7B53-46BE-9DE9-42234907C5E4

P921

Q41910113-BA851FC1-A5B2-43E0-9F5E-1A8801DB75D9

Q41910113-F994D00D-2288-4384-8E9B-38171C112C7A

P932

Q41910113-31957268-1364-4FB1-BE9E-A05DFAC73C96

P356

P1433

Clinical and translational gastroenterology

P1476

Higher activity of the inducib ...... et inflammatory bowel disease.

@en

P2093

Abdul Elkadri

http://www.w3.org/2001/XMLSchema#string

Aleixo M Muise

http://www.w3.org/2001/XMLSchema#string

Amanda Mack

http://www.w3.org/2001/XMLSchema#string

Christopher Griffiths

http://www.w3.org/2001/XMLSchema#string

Conghui Guo

http://www.w3.org/2001/XMLSchema#string

Cornelia Thöni

http://www.w3.org/2001/XMLSchema#string

David Mack

http://www.w3.org/2001/XMLSchema#string

Hien Huynh

http://www.w3.org/2001/XMLSchema#string

John H Brumell

http://www.w3.org/2001/XMLSchema#string

Lucas A Mastropaolo

http://www.w3.org/2001/XMLSchema#string

P2860

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

Common variants at five new loci associated with early-onset inflammatory bowel disease

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease

NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2

Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47

A genome-wide association study of global gene expression

Inflammatory bowel disease

Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data.

Arginase II restricts host defense to Helicobacter pylori by attenuating inducible nitric oxide synthase translation in macrophages

P304

e46

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CTG.2013.17

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259766589

http://www.w3.org/2001/XMLSchema#string

P698

24430113

http://www.w3.org/2001/XMLSchema#string

P921

Very early onset inflammatory bowel disease

inflammatory bowel diseases

P932

3912315

http://www.w3.org/2001/XMLSchema#string